Live feed07:30:00·200dPRReleasevia QuantisnowDRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)ByQuantisnow·Wall Street's wire, on your screen.VRDN· Viridian Therapeutics Inc.Health Care
